Recruiting

Observational Study

Sponsor:

Mayo Clinic

Code:

NCT06953245

Conditions

Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Non-Interventional Study

Study Details

Brief summary:

This study evaluates patient-reported experiences of radiation dermatitis in patients with breast cancer undergoing radiotherapy.

Conditions

Breast Carcinoma

Study ID

NCT06953245

Start date

Apr 30, 2025

Status verified date

Mar, 2026

Completion date

Jun 1, 2027

Anticipated

Primary completion date

Jun 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adults ≥ 18
  • Patients diagnosed with breast cancer
  • Currently undergoing or recently completed radiotherapy
  • Willing to provide verbal/oral consent
  • Willing to be recorded as they are answering the survey questions

Exclusion Criteria:

  • Persons < 18
  • Inability to provide verbal consent
  • Non-English speakers (unless translations are available)
  • Not willing to be recorded

Study Design

Enrollment

20 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational

Patients complete a survey on study, completed as a brief interview.

Interventions

Non-Interventional Study

Non-interventional study

Primary outcome measure

  • Patient experiences with radiation dermatitis [ Time Frame: Baseline (at enrollment) ]

Central Contacts and Locations

Central contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Locations

Mayo Clinic in Rochester

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Principal Investigator:

Kimberly S. Corbin, MD

More Information

Sponsor

Mayo Clinic

Last update posted

Apr 1, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-04-01.